Evidence map›Paper›PMID 24535998›Full record

ArticleJournal of nephrology2014

GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study.

Asahi Hishida, Naoyuki Takashima, Tanvir Chowdhury Turin, Sayo Kawai, Kenji Wakai, Nobuyuki Hamajima, Satoyo Hosono, Yuichiro Nishida, Sadao Suzuki, Noriko Nakahata and 7 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06222476 (A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06222476 naunknown statusnot on this mapstarted 2024, after this paper: background citation

A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.

TypeinterventionalSponsorYan BiRan2024 to 2026Enrolled106ConditionsDiabetic Nephropathy Type 2ArmsDorzagliatin, Gliclazide
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Asahi HishidaNagoya University Graduate School of Medicine, Nagoya, Japan, ah758u.unc@gmail.com.
Naoyuki Takashima
Tanvir Chowdhury Turin
Sayo Kawai
Kenji Wakai
Nobuyuki Hamajima
Satoyo Hosono
Yuichiro Nishida
Sadao Suzuki
Noriko Nakahata
Haruo Mikami
Keizo Ohnaka
Daisuke Matsui
Sakurako Katsuura-Kamano
Michiaki Kubo
Hideo Tanaka
Yoshikuni Kita
Nagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is well known as a strong risk factor for both of end-stage renal disease and cardiovascular disease. To clarify the association of glucokinase and glucokinase regulatory protein (GCKR) polymorphisms with the risk of CKD in Japan, we examined this association among Japanese individuals using cross-sectional data.

methodsThe subjects for this analysis were 3,314 consecutively selected participants from the Japan Multi-Institutional Collaborative Cohort Study. Age- and sex- adjusted odds ratios (aORs) of CKD stages 3-5 were calculated for each genotype by logistic regression and the effects of genotype on estimated glomerular filtration rate were evaluated by linear regression. Gene-environment interaction was also investigated based on questionnaire information.

resultsWhen subjects with GCKR rs780094 G/A and G/G, or GCKR rs1260326 T/C and C/C were combined together and compared with the references (GCKR rs780094 A/A or GCKR rs1260326 T/T), the aORs were 0.84 (0.69-1.02) or 0.81 (0.67-0.99) (p = 0.075 or 0.037), respectively. A significant OR for interaction between GCKR rs1260326 T/T and current smoking (OR = 1.79, p = 0.041) was also observed.

conclusionThe present study suggests a possible association of the T/T genotype of GCKR rs1260326 polymorphism with elevated risk of CKD and its interaction with current smoking, which may support the possibility of performing risk evaluation and prevention of this potentially life-threatening disease based on genetic traits in the near future.

Indexed as

AgedCarrier ProteinsCross-Sectional StudiesFemaleGenotypeGlucokinaseHumansJapanLife StyleMaleMiddle AgedPolymorphism, GeneticRenal Insufficiency, ChronicRisk FactorsSmokingSurveys and QuestionnairesCarrier ProteinsGlucokinaseglucokinase regulatory protein

Identifiers

PMID24535998
OpenAlexW1971104067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.